Patients With Advanced HIV May Not Benefit From Empiric Tuberculosis Treatment

By Dr Deepu

Medscape (7/28, Harrison) reports that a study suggests that “whether patients with advanced HIV receive empiric treatment for tuberculosis (TB), which they frequently die from, or isoniazid preventive therapy, there is no difference in mortality rates.” The findings were presented during the 8th International AIDS Society Conference.